PIONEERING BIOSIMILARS Trademark

Trademark Overview

On Thursday, February 16, 2012, a trademark application was filed for PIONEERING BIOSIMILARS with the United States Patent and Trademark Office. The USPTO has given the PIONEERING BIOSIMILARS trademark a serial number of 85544362. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 5, 2015. This trademark is owned by Novartis AG. The PIONEERING BIOSIMILARS trademark is filed in the Pharmaceutical Products category with the following description:

A full line of pharmaceutical preparations
pioneering biosimilars

General Information

Serial Number85544362
Word MarkPIONEERING BIOSIMILARS
Filing DateThursday, February 16, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 5, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 10, 2012

Trademark Statements

Disclaimer with Predetermined Text"BIOSIMILARS"
Goods and ServicesA full line of pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 23, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, October 5, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 5, 2015ABANDONMENT - NO USE STATEMENT FILED
Saturday, March 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2015EXTENSION 5 GRANTED
Tuesday, March 3, 2015EXTENSION 5 FILED
Tuesday, March 3, 2015TEAS EXTENSION RECEIVED
Wednesday, September 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 9, 2014EXTENSION 4 GRANTED
Wednesday, September 3, 2014EXTENSION 4 FILED
Wednesday, September 3, 2014TEAS EXTENSION RECEIVED
Friday, March 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 13, 2014EXTENSION 3 GRANTED
Monday, March 3, 2014EXTENSION 3 FILED
Monday, March 3, 2014TEAS EXTENSION RECEIVED
Friday, October 4, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2013EXTENSION 2 GRANTED
Friday, August 30, 2013EXTENSION 2 FILED
Thursday, October 3, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 30, 2013TEAS EXTENSION RECEIVED
Tuesday, March 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, March 3, 2013EXTENSION 1 GRANTED
Sunday, March 3, 2013EXTENSION 1 FILED
Sunday, March 3, 2013TEAS EXTENSION RECEIVED
Tuesday, September 4, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 20, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 6, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 6, 2012ASSIGNED TO LIE
Thursday, May 17, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 17, 2012EXAMINER'S AMENDMENT ENTERED
Thursday, May 17, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 17, 2012EXAMINERS AMENDMENT E-MAILED
Thursday, May 17, 2012EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 15, 2012ASSIGNED TO EXAMINER
Thursday, February 23, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 20, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

biosimilars pioneering preparations pharmaceutical line full